Compare Moderna, Inc. (MRNA) vs First Trust NASDAQ Clean Edge Green Energy Idx Fd (QCLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs First Trust NASDAQ Clean Edge Green Energy Idx Fd — how do they compare? Moderna, Inc. trades at $63.61 (market cap $24.18B), while First Trust NASDAQ Clean Edge Green Energy Idx Fd trades at $53.21. The key difference: Moderna, Inc. is trading nearer its 52-week high, First Trust NASDAQ Clean Edge Green Energy Idx Fd nearer its low. Which is the better fit depends on your goals.
| MRNA | QCLN | |
|---|---|---|
Market Cap | $24.18B | — |
Sector | Health | Sector/Thematic |
52-Week High | $81.80 | $68.47 |
52-Week Low | $22.36 | $36.11 |
Enterprise Value | $20.33B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Moderna (MRNA) trades at $63.70, up 6.5% recently, with a bullish technical signal and strong moving average support. Despite negative net income margins, the company beat Q2 2026 EPS estimates and secured FDA approval for its mRNA flu vaccine, mFLUSIVA, signaling diversification beyond COVID-19. Revenue has declined from pandemic peaks but is projected to stabilize around $2.2B in 2026.
The outlook is mixed: near-term catalysts from new vaccine approvals and pipeline progress offer upside, but persistent losses and high valuation multiples pose risks. Analyst consensus is cautious with a hold-heavy rating, reflecting uncertainty over profitability timelines amid ongoing R&D investments.
QCLN trades at $53.09, up 2.0% with a bullish technical signal from moving averages. The ETF benefits from clean energy sector momentum driven by data center power demand and global energy security concerns. Recent news highlights clean energy ETF gains amid volatile oil markets, though regulatory challenges and supply chain pressures present headwinds. Key support sits at $51-52 with resistance at $53-55.
The outlook remains positive given structural energy transition trends, but investors face regulatory uncertainty from U.S. permit delays and China trade tensions. Wall Street sentiment leans bullish on clean energy themes, though valuation metrics are unavailable for this ETF. Risks include geopolitical supply chain disruptions and policy shifts affecting renewable project economics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About First Trust NASDAQ Clean Edge Green Energy Idx Fd
QCLN invests in U.S.-listed companies engaged in clean energy technologies. It focuses on solar power, wind, electric vehicles, and energy storage, with major holdings in firms like Tesla, ON Semiconductor, and Rivian.
Read more on QCLN →
